Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD L 506 (Gliolan, 5-ALA) for intraoperative visualization of breast cancer tissue
2009-016842-22Phase 2Terminated
- Sponsor
- photonamic GmbH & Co. KG
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 5-aminolevulinic acid in breast cancer, sponsored by photonamic GmbH & Co. KG. Primary endpoint: Mean PPIX fluorescence intensity in breast cancer tissue. Started Jan 2010; status: terminated.
02
Drugs
5-aminolevulinic acid
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2009-016842-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016842-22.